174 related articles for article (PubMed ID: 20976192)
1. Diacylglycerol kinase β knockout mice exhibit lithium-sensitive behavioral abnormalities.
Kakefuda K; Oyagi A; Ishisaka M; Tsuruma K; Shimazawa M; Yokota K; Shirai Y; Horie K; Saito N; Takeda J; Hara H
PLoS One; 2010 Oct; 5(10):e13447. PubMed ID: 20976192
[TBL] [Abstract][Full Text] [Related]
2. Diacylglycerol kinase β knockout mice exhibit attention-deficit behavior and an abnormal response on methylphenidate-induced hyperactivity.
Ishisaka M; Kakefuda K; Oyagi A; Ono Y; Tsuruma K; Shimazawa M; Kitaichi K; Hara H
PLoS One; 2012; 7(5):e37058. PubMed ID: 22590645
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of diacylglycerol kinase η induces lithium-sensitive mania-like behavior.
Isozaki T; Komenoi S; Lu Q; Usuki T; Tomokata S; Matsutomo D; Sakai H; Bando K; Kiyonari H; Sakane F
J Neurochem; 2016 Aug; 138(3):448-56. PubMed ID: 27167678
[TBL] [Abstract][Full Text] [Related]
4. Essential role of neuron-enriched diacylglycerol kinase (DGK), DGKbeta in neurite spine formation, contributing to cognitive function.
Shirai Y; Kouzuki T; Kakefuda K; Moriguchi S; Oyagi A; Horie K; Morita SY; Shimazawa M; Fukunaga K; Takeda J; Saito N; Hara H
PLoS One; 2010 Jul; 5(7):e11602. PubMed ID: 20657643
[TBL] [Abstract][Full Text] [Related]
5. The effects of valproate and olanzapine on the abnormal behavior of diacylglycerol kinase β knockout mice.
Ishisaka M; Tsujii S; Mizoguchi T; Tsuruma K; Shimazawa M; Hara H
Pharmacol Rep; 2015 Apr; 67(2):275-80. PubMed ID: 25712650
[TBL] [Abstract][Full Text] [Related]
6. Memantine, an NMDA receptor antagonist, improves working memory deficits in DGKβ knockout mice.
Kakefuda K; Ishisaka M; Tsuruma K; Shimazawa M; Hara H
Neurosci Lett; 2016 Sep; 630():228-232. PubMed ID: 27495014
[TBL] [Abstract][Full Text] [Related]
7. Involvement of diacylglycerol kinase β in the spine formation at distal dendrites of striatal medium spiny neurons.
Hozumi Y; Kakefuda K; Yamasaki M; Watanabe M; Hara H; Goto K
Brain Res; 2015 Jan; 1594():36-45. PubMed ID: 25446448
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
[TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol kinase beta promotes dendritic outgrowth and spine maturation in developing hippocampal neurons.
Hozumi Y; Watanabe M; Otani K; Goto K
BMC Neurosci; 2009 Aug; 10():99. PubMed ID: 19691842
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice.
O'Brien WT; Huang J; Buccafusca R; Garskof J; Valvezan AJ; Berry GT; Klein PS
J Clin Invest; 2011 Sep; 121(9):3756-62. PubMed ID: 21821916
[TBL] [Abstract][Full Text] [Related]
11. Diacylglycerol kinase beta accumulates on the perisynaptic site of medium spiny neurons in the striatum.
Hozumi Y; Fukaya M; Adachi N; Saito N; Otani K; Kondo H; Watanabe M; Goto K
Eur J Neurosci; 2008 Dec; 28(12):2409-22. PubMed ID: 19087171
[TBL] [Abstract][Full Text] [Related]
12. Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.
Wong P; Sze Y; Chang CC; Lee J; Zhang X
Transl Psychiatry; 2015 Mar; 5(3):e528. PubMed ID: 25781227
[TBL] [Abstract][Full Text] [Related]
13. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
14. Lithium ameliorates open-field and elevated plus maze behaviors, and brain phospho-glycogen synthase kinase 3-beta expression in fragile X syndrome model mice.
Chen X; Sun W; Pan Y; Yang Q; Cao K; Zhang J; Zhang Y; Chen M; Chen F; Huang Y; Dai L; Chen S
Neurosciences (Riyadh); 2013 Oct; 18(4):356-62. PubMed ID: 24141459
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of a neuron-specific diacylglycerol kinase beta and gamma in the developing rat brain.
Adachi N; Oyasu M; Taniguchi T; Yamaguchi Y; Takenaka R; Shirai Y; Saito N
Brain Res Mol Brain Res; 2005 Oct; 139(2):288-99. PubMed ID: 16019106
[TBL] [Abstract][Full Text] [Related]
16. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.
O'Brien WT; Harper AD; Jové F; Woodgett JR; Maretto S; Piccolo S; Klein PS
J Neurosci; 2004 Jul; 24(30):6791-8. PubMed ID: 15282284
[TBL] [Abstract][Full Text] [Related]
18. Chronic stress affects PERIOD2 expression through glycogen synthase kinase-3β phosphorylation in the central clock.
Kinoshita C; Miyazaki K; Ishida N
Neuroreport; 2012 Jan; 23(2):98-102. PubMed ID: 22158133
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.
De Sarno P; Li X; Jope RS
Neuropharmacology; 2002 Dec; 43(7):1158-64. PubMed ID: 12504922
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and pharmacological phenotypes of brain-specific diacylglycerol kinase δ-knockout mice.
Usuki T; Takato T; Lu Q; Sakai H; Bando K; Kiyonari H; Sakane F
Brain Res; 2016 Oct; 1648(Pt A):193-201. PubMed ID: 27423518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]